Marketing Agreements in the Pharmaceuticals Industry
43 Contracts & Agreements
- Altus Pharmaceuticals Inc. (2 contracts)
- AngioGenex, Inc. (1)
- Applied BioSciences Corp. (1)
- Assertio Therapeutics, Inc (1)
- Biostar Pharmaceuticals, Inc. (1)
- Boston Therapeutics, Inc. (1)
- CANNAPOWDER, INC. (1)
- DUSA PHARMACEUTICALS INC (2)
- Exactus, Inc. (1)
- HARROW HEALTH, INC. (2)
- Lexaria Bioscience Corp. (3)
- ONYX PHARMACEUTICALS INC (1)
- OSCIENT PHARMACEUTICALS CORP (1)
- Pacira Pharmaceuticals, Inc. (4)
- Panacea Acquisition Corp (2)
- SGX PHARMACEUTICALS, INC. (16)
- Sucampo Pharmaceuticals, Inc. (1)
- TAURIGA SCIENCES, INC. (1)
- Valera Pharmaceuticals Inc (1)
- Licensing, Marketing, Supply and Development Agreement dated May 13, 2024 by and between the Issuer and Sky Wellness, LLC (Exactus, Inc., Filed With SEC on May 16, 2024)
- Business Combination Marketing Agreement, dated June 30, 2020, between the Company and Cowen and Company, LLC (Panacea Acquisition Corp, Filed With SEC on July 6, 2020)
- Form of Business Combination Marketing Agreement (Panacea Acquisition Corp, Filed With SEC on June 23, 2020)
- Agreement with Vice President of Distribution & Marketing date May 11, 2019 (TAURIGA SCIENCES, INC., Filed With SEC on August 13, 2019)
- Service Agreement, dated May 1, 2019, between Canna Powder Ltd. and One of a kind marketing DUSA LLC (CANNAPOWDER, INC., Filed With SEC on June 13, 2019)
- Marketing and Distribution Agreement, dated May 30, 2018, by and between the Company and MTN Distribution LLC, a Colorado limited liability company (Applied BioSciences Corp., Filed With SEC on June 28, 2018)
- Marketing Agreement dated March 24, 2017 with Dig Media Inc (Lexaria Bioscience Corp., Filed With SEC on January 5, 2018)
- STRATEGICSALES & MARKETING AGREEMENT (HARROW HEALTH, INC., Filed With SEC on May 2, 2017)
- STRATEGICSALES & MARKETING AGREEMENT (HARROW HEALTH, INC., Filed With SEC on April 17, 2017)
- Marketing Agreement between Boston Therapeutics, Inc. Benchworks SD LLC dated as of May 14, 2014 (Boston Therapeutics, Inc., Filed With SEC on November 7, 2014)
- Online Marketing Agreement dated March 12, 2014 (Lexaria Bioscience Corp., Filed With SEC on March 12, 2014)
- Social Media/Web Marketing Agreement dated March 10, 2014 (Lexaria Bioscience Corp., Filed With SEC on March 10, 2014)
- DATED SEPTEMBER 25, 2007 PACIRA PHARMACEUTICALS, INC. and FLYNN PHARMA LIMITED STRATEGIC MARKETING AGREEMENT (Pacira Pharmaceuticals, Inc., Filed With SEC on January 13, 2011)
- DATED: OCTOBER 15, 2009 PACIRA PHARMACEUTICALS, INC. and EKR THERAPEUTICS, INC. AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (Pacira Pharmaceuticals, Inc., Filed With SEC on January 13, 2011)
- DATED SEPTEMBER 25, 2007 PACIRA PHARMACEUTICALS, INC. and FLYNN PHARMA LIMITED STRATEGIC MARKETING AGREEMENT (Pacira Pharmaceuticals, Inc., Filed With SEC on December 3, 2010)
- DATED: OCTOBER 15, 2009 PACIRA PHARMACEUTICALS, INC. and EKR THERAPEUTICS, INC. AMENDED AND RESTATED STRATEGIC LICENSING, DISTRIBUTION AND MARKETING AGREEMENT (Pacira Pharmaceuticals, Inc., Filed With SEC on December 3, 2010)
- MODIFICATION TO DEVELOPMENT AND MARKETING AGREEMENT (AngioGenex, Inc., Filed With SEC on July 25, 2008)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 27, 2008)
- Drugs supply and marketing contract Contract No.: SY1-0701 Signatureplace: Xianyang Sale Region: Guangdong Province (Biostar Pharmaceuticals, Inc., Filed With SEC on February 25, 2008)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 30, 2007)
- EX-10.NN: FIRST AMENDMENT TO MARKETING DISTRIBUTION AND SUPPLY AGREEMENT (DUSA PHARMACEUTICALS INC, Filed With SEC on March 16, 2007)
- EX-10.MM: MARKETING DISTRIBUTION AND SUPPLY AGREEMENT (DUSA PHARMACEUTICALS INC, Filed With SEC on March 16, 2007)
- COPROMOTION AND MARKETING SERVICESAGREEMENT by and between VALERA PHARMACEUTICALS, INC. and INDEVUS PHARMACEUTICALS, INC. (Valera Pharmaceuticals Inc, Filed With SEC on January 26, 2007)
- SUPPLY, DISTRIBUTION AND MARKETING AGREEMENT (OSCIENT PHARMACEUTICALS CORP, Filed With SEC on November 9, 2006)
- Executive Salary Mariam E. Morris ChiefFinancial Officer and Treasurer $ 160,000 Brad E. Fackler ExecutiveVice President of Commercial Operations $ 220,000 Gayle R. Dolecek Senior... (Sucampo Pharmaceuticals, Inc., Filed With SEC on June 19, 2006)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 31, 2006)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 31, 2006)
- Marketing Rights (SGX PHARMACEUTICALS, INC., Filed With SEC on March 31, 2006)
- EX-10.16 DEVELOPMENT, COMMERCIALIZATION AND MARKETING AGREEMENT (Altus Pharmaceuticals Inc., Filed With SEC on January 11, 2006)
